HomeCompareSNANF vs MRK

SNANF vs MRK: Dividend Comparison 2026

SNANF yields 847.46% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SNANF wins by $4523283.17M in total portfolio value
10 years
SNANF
SNANF
● Live price
847.46%
Share price
$0.24
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4523283.22M
Annual income
$3,671,127,043,843.25
Full SNANF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SNANF vs MRK

📍 SNANF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNANFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNANF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNANF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNANF
Annual income on $10K today (after 15% tax)
$72,033.90/yr
After 10yr DRIP, annual income (after tax)
$3,120,457,987,266.76/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SNANF beats the other by $3,120,457,978,938.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNANF + MRK for your $10,000?

SNANF: 50%MRK: 50%
100% MRK50/50100% SNANF
Portfolio after 10yr
$2261641.64M
Annual income
$1,835,563,526,820.69/yr
Blended yield
81.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SNANF
No analyst data
Altman Z
-18.1
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNANF buys
0
MRK buys
0
No recent congressional trades found for SNANF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNANFMRK
Forward yield847.46%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4523283.22M$56.8K
Annual income after 10y$3,671,127,043,843.25$9,798.13
Total dividends collected$4456530.45M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SNANF vs MRK ($10,000, DRIP)

YearSNANF PortfolioSNANF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$95,446$84,745.76$11,206$366.19+$84.2KSNANF
2$858,073$755,946.16$12,650$502.35+$845.4KSNANF
3$7,269,615$6,351,477.15$14,407$694.19+$7.26MSNANF
4$58,068,078$50,289,589.98$16,585$967.82+$58.05MSNANF
5$437,555,378$375,422,534.13$19,342$1,363.89+$437.54MSNANF
6$3,112,005,757$2,643,821,502.80$22,913$1,947.19+$3111.98MSNANF
7$20,903,243,083$17,573,396,922.74$27,662$2,823.89+$20903.22MSNANF
8$132,684,175,477$110,317,705,377.58$34,159$4,173.35+$132684.14MSNANF
9$796,407,645,379$654,435,577,618.91$43,337$6,308.80+$796407.60MSNANF
10$4,523,283,224,399$3,671,127,043,843.25$56,776$9,798.13+$4523283.17MSNANF

SNANF vs MRK: Complete Analysis 2026

SNANFStock

Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.

Full SNANF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SNANF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNANF vs SCHDSNANF vs JEPISNANF vs OSNANF vs KOSNANF vs MAINSNANF vs JNJSNANF vs ABBVSNANF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.